123 related articles for article (PubMed ID: 14714955)
41. Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma.
Avilés A; Neri N; Castañeda C; Talavera A; Huerta-Guzmán J; González M
Med Oncol; 2002; 19(1):55-8. PubMed ID: 12025891
[TBL] [Abstract][Full Text] [Related]
42. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
[No Abstract] [Full Text] [Related]
43. [Efficacy of R±BEACOP regimen in patients with
poor-prognosis lymphoma].
Dong F; Pang Y; Wang J; Ke X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):858-63. PubMed ID: 26333493
[TBL] [Abstract][Full Text] [Related]
44. B cell lymphoma-associated hemophagocytic syndrome after PBSCT.
Takahashi T; Kanda Y; Mori M; Saito T; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Mar; 21(6):623-5. PubMed ID: 9543068
[TBL] [Abstract][Full Text] [Related]
45. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
47. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
48. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Jabbour E; Peslin N; Arnaud P; Ferme C; Carde P; Vantelon JM; Bocaccio C; Bourhis JH; Koscielny S; Ribrag V
Leuk Lymphoma; 2005 Jun; 46(6):861-7. PubMed ID: 16019530
[TBL] [Abstract][Full Text] [Related]
50. Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).
Wannesson L; Bargetzi M; Cairoli A; Cerutti A; Heim D; Hess U; Lerch E; Pabst T; Renner C; Samaras P; Zucca E
Leuk Lymphoma; 2013 Jan; 54(1):36-40. PubMed ID: 22702653
[TBL] [Abstract][Full Text] [Related]
51. Peripheral blood T cell subsets as prognostic indicators of chemotherapy outcome in AIDS patients with large cell lymphoma.
Patarca R; Freidlander A; Harrington WJ; Cabral L; Byrnes JJ; Fletcher MA
AIDS Res Hum Retroviruses; 1996 May; 12(8):645-9. PubMed ID: 8744574
[No Abstract] [Full Text] [Related]
52. [A case of primary malignant lymphoma of the duodenum successfully treated with dose escalating chemotherapy].
Oshiro A; Nagasaki A; Nakachi A; Uchima N; Hasegawa H; Nakazato T; Nakamoto M; Kinjo N; Kinjo F; Taira N; Masuda M; Takasu N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1169-73. PubMed ID: 12938276
[TBL] [Abstract][Full Text] [Related]
53. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
54. [Primary non-Hodgkin's lymphoma of paranasal sinuses. Review of the literature and a case report].
Bianconcini G; Mazzali F; Candini R; Dallasta A; Gobbi F
Minerva Med; 1992 Oct; 83(10):653-61. PubMed ID: 1281296
[TBL] [Abstract][Full Text] [Related]
55. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Vranovsky A; Ladicka M; Lakota J
Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043
[TBL] [Abstract][Full Text] [Related]
56. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
[TBL] [Abstract][Full Text] [Related]
57. [Primary lymphoma of the thyroid with contralateral recurrence--case report].
Pichler R; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Maschek W
Wien Klin Wochenschr; 1999 Apr; 111(8):329-32. PubMed ID: 10378315
[TBL] [Abstract][Full Text] [Related]
58. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
Chihara D; Westin JR; Miranda RN; Cheah CY; Oki Y; Turturro F; Romaguera JE; Neelapu SS; Nastoupil LJ; Fayad LE; Rodriguez MA; Fowler NH; Orlowski RZ; Wang M; Hagemeister FB; Medeiros LJ; Fanale MA
Br J Haematol; 2017 Nov; 179(3):503-506. PubMed ID: 27378601
[No Abstract] [Full Text] [Related]
59. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
60. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]